Tag:
rifaximin
Latest Headlines
Latest Headlines
Salix braces for harsh panel review of Xifaxan
Salix Pharmaceuticals is headed for its scheduled showdown today with a panel of FDA experts who are expected to grill the company on Xifaxan (rifaximin), a drug that is being prepped for the hepatic
Salix shares surge on promising pivotal data
Shares of Salix Pharmaceuticals (SLXP) jumped 35 percent in premarket trading after the company announced that its two late-stage trials for a new therapy for non-constipation irritable bowel
Salix raising $50M to find new drug deals
With its revenue taking a nasty hit from new generic competition, Salix Pharmaceuticals says it will arm itself with a cache of $50 million from the sale of convertible notes to fund in-licensing
